TM6SF2 and metabolic dysfunction-associated steatotic liver disease: Experimental and clinical studies in NAFLD show that the TM6SF2 T allele is associated with decreased TM6SF2 gene expression and consequent hepatic accumulation of lipids and triglycerides.